Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Mannitol 10% Solution for Infusion BP
Medicines register · Ireland

Mannitol 10% Solution for Infusion BP

Authorisation PA2299/006/001 · Baxter Holding B.V.

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 21 Nov 2026
Licence holder
Baxter Holding B.V. (all products →)
Active substance
Mannitol
Clinical trials
10 clinical trials →
Dosage form
Solution for infusion
Route of administration
Intravenous use
ATC codes
B05BC, B05BC01
First authorised
14/09/2007
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Well-established use application (Article 10a of Directive No 2001/83/EC)

Mannitol: supply and approvals

4 authorised products on the HPRA list contain Mannitol. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
Bronchitol: Shortage ongoing, first published 14 Nov 2025
US shortage (FDA)
No entry in the FDA drug shortage list (checked 20 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 20 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 19 years (since 14 September 2007). The HPRA list marks it as marketed in Ireland.

Other medicines with Mannitol in Ireland

3 other products on the HPRA list contain Mannitol, from 2 licence holders; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Celsior solution for organ preservationInstitut Georges Lopez - IGLNational authorisation (PA)Marketed
Osmohale, inhalation powder, hard capsulePharmaxis Europe LimitedNational authorisation (PA)Marketed
Bronchitol 40 mg inhalation powder, hard capsulesPharmaxis Europe LimitedCentralised EU authorisationNot stated

The licence holder

Baxter Holding B.V. holds 73 products on the HPRA list, with 111 different active substances; 62 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.